Bicocca Open Archive

Logo unimib boa
CONTI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.459
AS - Asia 5.580
EU - Europa 5.102
SA - Sud America 831
Continente sconosciuto - Info sul continente non disponibili 744
AF - Africa 150
OC - Oceania 16
Totale 24.882
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.861
SG - Singapore 1.880
IT - Italia 1.399
CN - Cina 1.164
VN - Vietnam 897
DE - Germania 808
RU - Federazione Russa 637
HK - Hong Kong 629
BR - Brasile 596
CA - Canada 483
SE - Svezia 455
IE - Irlanda 364
GB - Regno Unito 351
UA - Ucraina 232
IN - India 223
FR - Francia 200
AT - Austria 150
FI - Finlandia 141
BD - Bangladesh 139
TR - Turchia 105
AR - Argentina 85
KR - Corea 82
ID - Indonesia 75
JP - Giappone 67
DK - Danimarca 65
IQ - Iraq 58
PK - Pakistan 52
PL - Polonia 52
ZA - Sudafrica 51
NL - Olanda 50
MX - Messico 46
ES - Italia 45
BE - Belgio 38
PH - Filippine 37
EC - Ecuador 35
CO - Colombia 33
SA - Arabia Saudita 29
VE - Venezuela 29
EG - Egitto 26
UZ - Uzbekistan 24
MA - Marocco 20
CZ - Repubblica Ceca 19
CL - Cile 18
CH - Svizzera 17
JM - Giamaica 17
CR - Costa Rica 15
MY - Malesia 14
AE - Emirati Arabi Uniti 13
EU - Europa 13
IR - Iran 13
LT - Lituania 13
AU - Australia 12
PE - Perù 11
DZ - Algeria 10
ET - Etiopia 9
HU - Ungheria 9
JO - Giordania 9
RO - Romania 9
TN - Tunisia 9
BO - Bolivia 8
KE - Kenya 8
PY - Paraguay 8
AL - Albania 7
NI - Nicaragua 7
PT - Portogallo 7
AZ - Azerbaigian 6
BH - Bahrain 6
PA - Panama 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
BG - Bulgaria 5
HN - Honduras 5
IL - Israele 5
KZ - Kazakistan 5
NP - Nepal 5
OM - Oman 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
GT - Guatemala 4
LV - Lettonia 4
MN - Mongolia 4
SI - Slovenia 4
SN - Senegal 4
BB - Barbados 3
BY - Bielorussia 3
KG - Kirghizistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
GA - Gabon 2
GR - Grecia 2
GY - Guiana 2
KH - Cambogia 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
RS - Serbia 2
Totale 24.125
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.175
Ashburn 1.174
Singapore 1.148
San Jose 777
Hong Kong 600
Chandler 534
Woodbridge 523
Milan 473
Frankfurt am Main 458
Wilmington 380
Houston 354
Dublin 352
Toronto 300
Fairfield 298
Ho Chi Minh City 295
Jacksonville 274
New York 258
Dearborn 252
Dallas 237
Council Bluffs 228
Santa Clara 221
Los Angeles 220
Hanoi 206
Beijing 169
Seattle 143
Chicago 141
The Dalles 138
Vienna 133
Princeton 131
Cambridge 109
Nanjing 98
Rome 98
Shanghai 85
Columbus 80
Buffalo 78
Boardman 74
São Paulo 74
Lauterbourg 72
Orem 68
Hefei 64
Phoenix 64
Seoul 62
Helsinki 53
Jakarta 52
Lachine 51
Tokyo 50
Guangzhou 48
Moscow 48
Denver 46
Munich 46
London 45
Atlanta 42
Brooklyn 40
Da Nang 40
Warsaw 40
Chennai 39
Brussels 37
Montreal 37
Lawrence 36
Nanchang 33
Haiphong 31
Dong Ket 30
Ottawa 30
Johannesburg 29
Nuremberg 26
San Diego 26
Shenyang 26
Dhaka 25
Pune 25
Baghdad 24
Boston 23
Stockholm 23
Tianjin 23
Fremont 22
Istanbul 22
Altamura 21
Biên Hòa 20
Lappeenranta 20
Brasília 19
Changsha 19
Tashkent 19
Andover 18
Falls Church 18
Manchester 18
Mumbai 18
Poplar 18
Rio de Janeiro 18
Amsterdam 17
Carate Brianza 17
Jinan 17
Philadelphia 17
Zhengzhou 17
Belo Horizonte 16
Norwalk 16
Quito 16
Charlotte 15
Hải Dương 15
Jiaxing 15
Lahore 15
Monza 15
Totale 15.220
Salva come PNG Salva come JPEG
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 585
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 522
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 515
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 494
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 491
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 477
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 467
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 467
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer’s disease 464
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 464
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 443
Anorexia nervosa in adolescent girls and celiac disease serology 426
Behavioural anomalies in neurodegenerative diseases: role of the immune response 403
The one-carbon metabolism in anorexia nervosa of the restrictive type 396
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 395
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 394
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 391
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 384
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 379
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 377
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 370
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 370
New insights into the genetic etiology of Alzheimer's disease and related dementias 364
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 363
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 351
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 350
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 347
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 343
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 342
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 338
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 338
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 335
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 331
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 324
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa 321
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 320
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 313
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 305
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 304
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 301
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 299
Anorexia nervosa of the restrictive type and celiac disease in adolescence 296
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 295
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 293
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 283
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 283
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 280
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 280
the MonzALS collaborative network 277
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 275
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 275
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 274
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 273
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 263
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 261
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 252
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 251
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 248
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 246
Affective states and pathology in adolescents with borderline personality 244
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 240
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 232
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data 227
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 221
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 218
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 214
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 212
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 211
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 207
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 205
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 194
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 192
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 189
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 189
Whole-blood global DNA methylation and phenotypic variability in ALS 185
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 178
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 160
Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type III 143
Cerebrospinal fluid CEFA composition is enriched in saturated fatty acids and it is altered in Alzheimer's Disease 124
Dementia risk factors and biomarkers in subjective cognitive decline: real world evidence from the monza brain health service 29
Totale 24.882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022703 0 0 0 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/20253.070 171 277 212 113 238 166 207 141 304 477 263 501
2025/20268.900 1.058 474 665 850 1.123 461 1.387 372 686 833 491 500
2026/20272.109 232 435 937 505 0 0 0 0 0 0 0 0
Totale 24.882